Health-related quality of life of COPD patients aged over 40 years.

CAT SF-36 SGRQ-C chronic obstructive pulmonary disease quality of life

Journal

Physiology international
ISSN: 2498-602X
Titre abrégé: Physiol Int
Pays: Hungary
ID NLM: 101696724

Informations de publication

Date de publication:
21 Jun 2021
Historique:
received: 08 02 2021
accepted: 27 04 2021
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 25 6 2021
Statut: aheadofprint

Résumé

Chronic obstructive pulmonary disease (COPD) is the fourth most frequent disease globally, and its worldwide prevalence is projected to increase in the following decades. Health-related quality of life (HRQOL) of COPD patients depends on multiple factors. The aim of this study was to identify the most important risk factors affecting HRQOL of COPD patients and to measure how specific clinical parameters can predict HRQOL. A questionnaire-based cross-sectional study combined with clinical data was conducted among patients diagnosed with COPD (n = 321, 52.6% females, mean age 66.4 ± 9.5) at the National Koranyi Institute for Pulmonology, Budapest in 2019-2020. The inclusion criteria were age ≥40 years and existing COPD. Multivariate linear regression analyses were conducted on three components of the COPD-specific Saint George's Respiratory Questionnaire (SGRQ-C) and on the physical (PCS) and mental component scales (MCS) of the 36-Item Short Form Health Survey (SF-36). Multiple linear regression analysis was performed to evaluate the effects of patient and disease characteristics on COPD Assessment Test (CAT) scores. We found that frequent exacerbations, multiple comorbidities and tobacco smoking were associated with worse HRQOL. Engaging in more frequent physical activity and better 6-minute walking distance results were associated with better HRQOL. Our results indicate that the complex therapy of COPD should focus not only on improving lung functions and preventing exacerbation, but also on treating comorbidities, encouraging increased physical activity, and supporting smoking cessation to assure better HRQOL for patients.

Sections du résumé

BACKGROUND BACKGROUND
Chronic obstructive pulmonary disease (COPD) is the fourth most frequent disease globally, and its worldwide prevalence is projected to increase in the following decades. Health-related quality of life (HRQOL) of COPD patients depends on multiple factors.
OBJECTIVE OBJECTIVE
The aim of this study was to identify the most important risk factors affecting HRQOL of COPD patients and to measure how specific clinical parameters can predict HRQOL.
METHODS METHODS
A questionnaire-based cross-sectional study combined with clinical data was conducted among patients diagnosed with COPD (n = 321, 52.6% females, mean age 66.4 ± 9.5) at the National Koranyi Institute for Pulmonology, Budapest in 2019-2020. The inclusion criteria were age ≥40 years and existing COPD. Multivariate linear regression analyses were conducted on three components of the COPD-specific Saint George's Respiratory Questionnaire (SGRQ-C) and on the physical (PCS) and mental component scales (MCS) of the 36-Item Short Form Health Survey (SF-36). Multiple linear regression analysis was performed to evaluate the effects of patient and disease characteristics on COPD Assessment Test (CAT) scores.
RESULTS RESULTS
We found that frequent exacerbations, multiple comorbidities and tobacco smoking were associated with worse HRQOL. Engaging in more frequent physical activity and better 6-minute walking distance results were associated with better HRQOL.
CONCLUSIONS CONCLUSIONS
Our results indicate that the complex therapy of COPD should focus not only on improving lung functions and preventing exacerbation, but also on treating comorbidities, encouraging increased physical activity, and supporting smoking cessation to assure better HRQOL for patients.

Identifiants

pubmed: 34166221
doi: 10.1556/2060.2021.00017
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

V Fazekas-Pongor (V)

1Department of Public Health, Faculty of Medicine, Semmelweis University, Budapest H-1085, Hungary.

M Fekete (M)

1Department of Public Health, Faculty of Medicine, Semmelweis University, Budapest H-1085, Hungary.

P Balazs (P)

1Department of Public Health, Faculty of Medicine, Semmelweis University, Budapest H-1085, Hungary.

D Árva (D)

1Department of Public Health, Faculty of Medicine, Semmelweis University, Budapest H-1085, Hungary.

M Pénzes (M)

1Department of Public Health, Faculty of Medicine, Semmelweis University, Budapest H-1085, Hungary.

S Tarantini (S)

2University of Oklahoma Health Sciences Center, Department of Biochemistry and Molecular Biology, Oklahoma City, OK 73132, USA.
3Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

R Urbán (R)

4Institute of Psychology, Eötvös Loránd University, Budapest H-1064, Hungary.

J T Varga (JT)

5Department of Pulmonology, Semmelweis University, Budapest, Hungary.

Classifications MeSH